Person and Family Engagement and Health Equity

Developed by American Institute of Research (AIR) in partnership with IPRO HQIC

Person and family engagement (PFE) is recognized by the Centers
for Medicare & Medicaid Services (CMS) as a promising way to
address health and health care disparities and achieve equity in
quality and safety. Applying PFE equitably means including
patients and families from all backgrounds as equal and active
partners in their health care. Doing so can help ensure that all
patients reap the benefits of engagement in their healthcare.

Health Disparities Road Map

Developed by American Institute of Research (AIR) in partnership with IPRO HQIC

This resource discussed how Person and Family Engagement can help hospitals achieve health Equity in Health Care Quality and Safety.

The American Institutes for Research (AIR)—a partner in the IPRO HQIC program—identified six overarching strategies to guide hospitals in meaningfully engaging patients and families in health care. This document describes how to apply these strategies in ways that can help hospitals achieve equity in care quality and safety and address barriers to uniform engagement.

The Importance of a PFAC at a Critical Access Hospital

American Institutes for Research

To motivate senior leaders at rural and critical access hospitals to create and engage Patient- and Family-Engagement Councils (or PFECs), the American Institutes for Research in the Behavioral Sciences (AIR) created a video testimonial with comments from the CEO, COO, PFEC staffer and patient representative at a critical access hospital in Truckee, CA on the benefits of a PFEC This 3.5 minute video was created as part of AIR’s Patient- and Family-Engagement efforts with the Hospital Improvement Innovation Networks (HIINs) in collaboration with the Health Services Advisory Group (HSAG) HIIN.

National Action Plan for Adverse Drug Event (ADE) Prevention; Office of Disease Prevention and Health Promotion (ODPHP)

The ADE Action Plan addresses a defined group of ADEs that are considered to be common, clinically significant, preventable, and measurable; resulting from high-priority drug classes; and occurring largely in high-risk populations. Three key drug classes identified as initial targets for the ADE Action Plan include; Anticoagulants (primary ADE of concern: bleeding), Diabetes agents (primary ADE of concern: hypoglycemia), and Opioids (primary ADE of concern: accidental overdoses, oversedation, respiratory depression).